Cargando…

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda

BACKGROUND: The World Health Organization (WHO) has endorsed the next-generation Xpert MTB/RIF Ultra (Ultra) cartridge, and Uganda is currently transitioning from the older generation Xpert MTB/RIF (Xpert) cartridge to Ultra as the initial diagnostic test for pulmonary tuberculosis (TB). We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andama, A., Jaganath, D., Crowder, R., Asege, L., Nakaye, M., Katumba, D., Mukwatamundu, J., Mwebe, S., Semitala, C. F., Worodria, W., Joloba, M., Mohanty, S., Somoskovi, A., Cattamanchi, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802232/ https://www.ncbi.nlm.nih.gov/pubmed/33430790 http://dx.doi.org/10.1186/s12879-020-05727-8

Ejemplares similares

Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
por: Yoon, Christina, et al.
Publicado: (2012)

Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda
por: Meyer, Amanda J., et al.
Publicado: (2017)

Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
por: Byanyima, Patrick, et al.
Publicado: (2022)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
por: Nalugwa, Talemwa, et al.
Publicado: (2020)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis
por: Hanrahan, Colleen F., et al.
Publicado: (2016)

Evaluation of multi-antigen serological screening for active tuberculosis among people living with HIV
por: Jaganath, Devan, et al.
Publicado: (2020)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Investigation of OMNIgene·SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda
por: Kelly-Cirino, C.D., et al.
Publicado: (2017)

Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients
por: Connelly, John T., et al.
Publicado: (2021)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Characterization of oral swab samples for diagnosis of pulmonary tuberculosis
por: Wood, Rachel C., et al.
Publicado: (2021)

Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up
por: Farr, Katherine, et al.
Publicado: (2019)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study
por: Walusimbi, Simon, et al.
Publicado: (2016)

Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study
por: Sekadde, Moorine Penninah, et al.
Publicado: (2013)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses
por: Kendall, Emily A., et al.
Publicado: (2019)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa
por: Dowdy, David W., et al.
Publicado: (2013)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out
por: Muttamba, Winters, et al.
Publicado: (2018)

Contribution of Xpert(®) MTB/RIF to pediatric TB diagnosis in Mozambique
por: Mutemba, C. M., et al.
Publicado: (2023)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis
por: Yu, Wenfeng, et al.
Publicado: (2022)

Evaluation of Cepheid's Xpert MTB/RIF Test on Pleural Fluid in the Diagnosis of Pleural Tuberculosis in a High Prevalence HIV/TB Setting
por: Lusiba, John K., et al.
Publicado: (2014)

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
por: Boulware, David R.
Publicado: (2013)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
por: Cayci, Yeliz Tanriverdi, et al.
Publicado: (2017)

Prevalence of Tuberculous Spondylodisciitis and Diagnostic Utility of Xpert MTB RIF
por: Ananthanarayanan, Rajalakshmi, et al.
Publicado: (2017)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Diagnostic role of Xpert-MTB RIF assay in osteoarticular tuberculosis: A retrospective study
por: Mohanty, Monalisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_83hdv6dluakhnh78hpv902b0b3